Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia

NCT02974179 is registered in ClinicalTrials.gov with AnGes USA, Inc. as lead sponsor.

NCT NCT02974179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia
Lead sponsor
AnGes USA, Inc.
Phase
Observational
Overall status
Completed
Start date
February 20, 2017
Completion date
January 10, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia